Table 2.
Clinical recommendations summary
FAS population (n = 96) | |
---|---|
Clinical recommendations made, n | 36 |
Patients given a clinical recommendation, n (%) | 20 (20.8) |
Number of clinical recommendations made per patienta, mean (SD) | 1.8 (1.7) |
Patients with a symptom alertb, n (%) | 87 (90.6) |
Elevated symptom score reportsb, n (%) | 2142 (17.4)c |
Patient treatment days with an elevated symptom scoreb,d, (%) | 13.1 |
Clinical recommendation (n = 36)e, n (%) | |
Transfer toll-free call | 4 (11.1) |
Connected toll-free call | 9 (25.0) |
Did not use toll-free number | 23 (63.9) |
Time to clinical recommendation (n = 34)f, (h) | |
Median (IQR) | 7.1 (4.0–29.9) |
Time to clinical recommendation by toll-free number (n = 11)f, (h) | |
Median (IQR) | 2.1 (0.0–7.2) |
Time to clinical recommendation by other form of contact (n = 23)f, (h) | |
Median (IQR) | 19.6 (4.5–45.3) |
FAS full analysis set, IQR interquartile range, SD standard deviation
aOnly calculated for patients given a clinical recommendation
bA daily symptom score is considered elevated (symptom alert) when a patient’s current daily symptom score is ≥ 1.0 point(s) higher compared with their baseline symptom score
cOut of a total of 12,342 symptom reports
dPatient days with an elevated symptom score = (number of elevated symptom score reports/sum of patients’ time on treatment) × 100
eClinical recommendations were received by 20 patients
fTime to clinical recommendation is calculated only for 34 clinical recommendations that were documented in the electronic data capture; 2 calls were not captured in the electronic data capture